Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
15,010,968
-
Share change
-
+691,508
-
Total reported value
-
$168,423,713
-
Put/Call ratio
-
0.37%
-
Price per share
-
$11.22
-
Number of holders
-
55
-
Value change
-
+$8,238,895
-
Number of buys
-
28
-
Number of sells
-
19
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2023
As of 31 Dec 2023,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,010,968 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Sonic GP LLC, Solas Capital Management, LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, DG Capital Management, LLC, BlackRock Inc., HARBERT FUND ADVISORS, INC., AIGH Capital Management LLC, and GENDELL JEFFREY L.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.